Literature DB >> 25929763

Retraction Note to: Suppression of the xCT-CD44v antiporter system sensitizes triple-negative breast cancer cells to doxorubicin. Breast Cancer Res Treat (2014) 147:203-10.

.   

Abstract

Entities:  

Year:  2015        PMID： 25929763     DOI： 10.1007/s10549-015-3399-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  2 in total

Review 1.  xCT: A Critical Molecule That Links Cancer Metabolism to Redox Signaling.

Authors:  Jinyun Liu; Xiaojun Xia; Peng Huang
Journal:  Mol Ther       Date:  2020-09-02       Impact factor: 11.454

2.  The down-regulation of SLC7A11 enhances ROS induced P-gp over-expression and drug resistance in MCF-7 breast cancer cells.

Authors:  Chun Ge; Bei Cao; Dong Feng; Fang Zhou; Jingwei Zhang; Na Yang; Siqi Feng; Guangji Wang; Jiye Aa
Journal:  Sci Rep       Date:  2017-06-19       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.